In the wake of the Diamond Action Plan for Biotech Takeoff, the government's drafting of the Biotech and New Pharmaceutical Development Statute and signing of the Economic Cooperation Framework Agreement (ECFA) and Cross-strait Cooperation Agreement on Medicine and Public Health Affairs with China will expand collaboration opportunities for the biotech industries in Taiwan and China, bring future market opportunities, and induce domestic and foreign firms to sharply increase their investment in the biotech industry.Furthermore, as demographic aging continues worldwide, healthcare reform in numerous countries and the continued growth of emergency markets will increase demand for pharmaceuticals and medical products,creating more opportunities for the biotech industry. In view of this background, the Diamond Action Plan for Biotech Takeoff will enable industry to take advantage of upstream R&D results and technologies at an early date, promote the establishment and development of R&D-oriented pharmaceutical and medical devices companies, attract investment by international capital, and transform Taiwan into a major biotech hub providing foreign firms with convenient access to the Asian market.
| Identifer | oai:union.ndltd.org:NSYSU/oai:NSYSU:etd-0802111-230840 |
| Date | 02 August 2011 |
| Creators | Wu, Jyun-yi |
| Contributors | Wen-cheng Lin, Hsien-chao Chang, Yu-jen kuo |
| Publisher | NSYSU |
| Source Sets | NSYSU Electronic Thesis and Dissertation Archive |
| Language | Cholon |
| Detected Language | English |
| Type | text |
| Format | application/pdf |
| Source | http://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0802111-230840 |
| Rights | user_define, Copyright information available at source archive |
Page generated in 0.0024 seconds